Hysterectomies are common because a surprisingly wide range of gynecological conditions, from fibroids to chronic pain disorders, have few effective long-term treatments that don’t involve removing the uterus. About 600,000 hysterectomies are performed each year in the United States, and roughly one in nine women will have one during their lifetime. That volume reflects both the biology of uterine conditions and the reality that, for several diagnoses, surgery remains the only reliable solution.
Fibroids Are the Leading Reason
Uterine fibroids, noncancerous growths in the wall of the uterus, are the single most common diagnosis leading to hysterectomy. They account for approximately 31% of all procedures. Fibroids can cause heavy menstrual bleeding severe enough to cause anemia, pelvic pressure, frequent urination, and pain during sex. Mild fibroids often respond to hormonal treatments or can be monitored without intervention, but when they grow large or cause debilitating symptoms, surgical removal of the uterus is frequently the recommended path.
Alternatives exist. Uterine artery embolization, a procedure that cuts off blood flow to the fibroids, avoids major surgery and works well for many women. In a major trial comparing embolization to surgery, however, about 9% of women who chose embolization needed a second procedure or eventual hysterectomy within the first year because their symptoms returned. After that first year, 11 more women were readmitted for the same problem. These re-intervention rates help explain why many doctors and patients still opt for hysterectomy as the more definitive choice, especially when a woman is done having children.
Conditions With No Other Definitive Cure
Adenomyosis is a condition where tissue that normally lines the uterus grows into the muscular wall, causing severe cramping, heavy periods, and a swollen uterus. It’s a major driver of hysterectomy for a simple reason: removing the uterus is the only treatment that reliably eliminates symptoms. Hormonal therapies and pain management can help, but high-quality evidence supporting conservative treatments is notably lacking. For women who aren’t planning future pregnancies or who have exhausted other options, hysterectomy often becomes the practical endpoint.
Endometriosis, where tissue similar to the uterine lining grows outside the uterus, accounts for about 15% of benign hysterectomies. It’s worth noting that hysterectomy doesn’t cure endometriosis since the tissue can exist elsewhere in the pelvis, but it can dramatically reduce symptoms for many women, particularly when other surgeries and medications haven’t worked. Endometriosis cases do carry higher surgical complexity. Postoperative complication rates run about 9.9% compared to 8.1% for hysterectomies without endometriosis, because the disease distorts pelvic anatomy and makes surgery harder.
Abnormal uterine bleeding that doesn’t respond to hormonal treatments or less invasive procedures is another common indication. Uterine prolapse, where the uterus drops into the vaginal canal due to weakened pelvic support, rounds out the major reasons. Each of these conditions shares a common thread: when symptoms are severe and other treatments fail or aren’t available, removing the uterus is the most reliable way to restore quality of life.
Racial Disparities Widen the Numbers
Hysterectomy rates are not evenly distributed across the population. A large study tracking women aged 33 to 45 found that 12% of Black women had undergone hysterectomy compared to 4% of white women. Black women had more than three and a half times the odds of having the procedure, and that gap persisted even after accounting for differences in education, income, BMI, geographic location, and access to care.
Biology plays a role. Fibroids are significantly more common in Black women. One study found that 67% of Black women showed evidence of fibroids on imaging compared to 39% of white women, regardless of whether they’d had a hysterectomy. But the disparity isn’t fully explained by fibroid prevalence alone. Researchers point to differences in how alternatives to hysterectomy are communicated to patients, delays in seeking care that allow conditions to progress beyond the point where conservative treatment is viable, and possible differences in physician recommendations based on race. The study’s authors could not attribute the racial gap to commonly measured socioeconomic or psychosocial factors, suggesting deeper systemic issues in how care is offered and received.
Fewer Hysterectomies Than a Decade Ago
Despite the high overall numbers, the trend has been declining. Annual hysterectomies in the U.S. peaked at about 681,000 in 2002 and dropped to roughly 434,000 by 2010. Several factors drove this shift. Minimally invasive alternatives became more widely available, hormonal IUDs offered new ways to manage heavy bleeding, and clinical guidelines began emphasizing uterus-sparing options when appropriate.
The way hysterectomies are performed has also changed substantially. Minimally invasive approaches, including laparoscopic and robotic-assisted surgery, grew from about 9% of procedures in 2006 to nearly 62% by 2011. These techniques involve smaller incisions, shorter hospital stays, and faster recovery compared to traditional open abdominal surgery. The shift hasn’t reduced the number of women who ultimately need hysterectomy, but it has made the experience significantly less physically burdensome for those who do.
Why the Numbers Stay High
The core reason hysterectomies remain so common is that the uterus is vulnerable to a cluster of conditions that are themselves extremely prevalent. Fibroids affect the majority of women by age 50. Endometriosis impacts roughly 10% of reproductive-age women. Adenomyosis is increasingly recognized as more widespread than previously thought. And for each of these, conservative treatments often work well enough for a while but fail to provide permanent relief.
There’s also a practical calculus many women and their doctors make. For someone who has spent years managing painful, disruptive symptoms and who doesn’t plan to become pregnant, a hysterectomy can represent not a loss but a resolution. The procedure carries real risks and a recovery period of several weeks, but it eliminates the underlying problem in a way that medications and less invasive procedures sometimes cannot. That combination of high disease prevalence, limited alternatives for severe cases, and genuine patient preference keeps hysterectomy among the most performed surgeries in the country.